KOSDAQ - Delayed Quote KRW

Seegene, Inc. (096530.KQ)

23,650.00

-450.00

(-1.87%)

At close: January 31 at 3:30:14 PM GMT+9

/C O R R E C T I O N -- Seegene Inc./

Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, held the first executive roundtable with Microsoft and Springer Nature to discuss advancing its technology-sharing initiative aimed at mitigating future pandemics and creating 'a world free from diseases', including the showcase of preliminary results from an automated diagnostic development system powered with Microsoft's artificial intelligence (AI) technology. This is the first official even

PR Newswire 3 months ago

096530.KQ
-1.87%
096530.KS
Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative

Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, held the first executive roundtable with Microsoft and Springer Nature to discuss advancing its technology-sharing initiative aimed at mitigating future pandemics and creating 'a world free from diseases', including the showcase of preliminary results from an automated diagnostic development system powered with Microsoft's artificial intelligence (AI) technology. This is the first official even

CNW Group 3 months ago

096530.KQ
-1.87%
096530.KS
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today the finalization of a partnership agreement with Werfen, a worldwide leader in specialized diagnostics, on the technology-sharing initiative. Under the agreement, Seegene and Werfen will set up a NewCo in Spain, Werfen-Seegene, upon the conclusion of mandatory government approvals anticipated by the first half of 2025.

CNW Group 3 months ago

096530.KQ
-1.87%
096530.KS
Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1

Seegene Inc., a leading provider of total solution for PCR molecular diagnostics based in South Korea, announced today that it will introduce a new type of research-use-only (RUO) PCR assay to address the spread of the mpox virus variant, Clade Ib, which is currently prevalent in Africa.

PR Newswire 4 months ago

096530.KQ
-1.87%
096530.KS
Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today an extension of its strategic partnership with Springer Nature, a trusted provider to the global scientific community and the publisher of the prestigious scientific journal, Nature.

CNW Group 4 months ago

096530.KQ
-1.87%
096530.KS
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today that it has developed its PCR test assays in response to the public health emergency of international concern (PHEIC) declared by the World Health Organization's (WHO) on the global spread of mpox.

PR Newswire 5 months ago

096530.KQ
-1.87%
096530.KS
Seegene Showcased its Multiplex Technology at ADLM 2024

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, showcased its key products and systems at the Association for Diagnostics & Laboratory Medicine 2024 (ADLM 2024) under the exhibition theme "One Sample, Many Answers." The event was held in Chicago from July 30 to August 1.

PR Newswire 5 months ago

096530.KQ
-1.87%
096530.KS
Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, demonstrated its human papillomavirus (HPV) diagnostic products and underscored the critical importance of HPV screening test at the Asia-Oceania Research Organization in Genital Infection and Neoplasia (AOGIN) conference, held in Seoul, South Korea from July 11-13.

PR Newswire 6 months ago

096530.KQ
-1.87%
096530.KS
Seegene and Springer Nature Announce Strategic Alliance

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on May 16th the signing of a strategic alliance agreement with Springer Nature, the publisher of the prestigious scientific journal, Nature.

PR Newswire 8 months ago

096530.KQ
-1.87%
096530.KS
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"

Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today that Prof. Dame Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), visited its headquarters located in Seoul Korea, on March 27.

PR Newswire 9 months ago

096530.KQ
-1.87%
096530.KS
Seegene and Springer Nature Announce Awardees for the Open Innovation Program

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, and Springer Nature, a world-leading provider of services to the research community, unveiled the final list of participants for the diagnostic reagent development project on March 15, 2024(GMT), through the online platform of the Open Innovation Program (https://openinnovation.seegene.com/open-innovation/2023-2024-announcements/).

PR Newswire 10 months ago

096530.KQ
-1.87%
096530.KS

Performance Overview

Return	096530.KQ	KOSPI Composite Index
YTD	+3.73%	+4.91%
1-Year	-3.27%	+0.81%
3-Year	-51.88%	-5.48%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Seegene, Inc. (096530.KQ)

/C O R R E C T I O N -- Seegene Inc./

Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1

Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays

Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration

Seegene Showcased its Multiplex Technology at ADLM 2024

Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024

Seegene and Springer Nature Announce Strategic Alliance

Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"

Seegene and Springer Nature Announce Awardees for the Open Innovation Program

Performance Overview